Advanced Solid Tumors: ITF3756 Treatment Study

We are testing a new oral medication for patients with advanced solid tumors to see if it is safe and effective, both alone and with another treatment. This study aims to understand how well it works in combination with an anti-protein 4 agent.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
European Institute Of Oncology S.r.l.
Divisione di Sviluppo di Nuovi Farmaci per Terapie Innovative
Opera, Italy
Humanitas Research Hospital
Medical Oncology Unit, Humanitas Cancer Center
Rozzano, Italy
IRCCS Istituto Nazionale Tumori - Fondazione Pascale
Melanoma, Cancer Immunotherapy and Development Therapeutics Unit
Soccavo, Italy

Sponsor: Italfarmaco S.p.A.
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.